Lewis, Richard A <br/><br/>
High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial.  [electronic resource] 

 -  JAMA neurology  Aug 2013 
 - 981-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2168-6157 
<br/><br/><label>Standard No.: </label>10.1001/jamaneurol.2013.3178  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Animals<br/>Antioxidants--administration & dosage<br/>Ascorbic Acid--administration & dosage<br/>Charcot-Marie-Tooth Disease--diagnosis<br/>Disease Models, Animal<br/>Disease Progression<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Medical Futility<br/>Mice<br/>Middle Aged<br/>Severity of Illness Index<br/>Time Factors<br/>Young Adult